Author:
Aapro M,Osterwalder B,Scherhag A,Burger H U
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Aapro M, Scherhag A, Burger HU (2008a) Effect of treatment with epoetin beta on survival, tumour progression and thromboembolic events in patients with metastatic cancer: an updated meta-analysis of 12 randomized controlled studies including 2301 patients. Br J Cancer 99 (1): 14–22
2. Aapro M, Leonard RC, Barnadas A, Marangolo M, Untch M, Malamos N, Mayordomo J, Reichert D, Pedrini JL, Ukarma L, Scherhag A, Burger H-U (2008b) Effect of once weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy – results of the BRAVE study. J Clin Oncol 26: 592–598
3. Aapro M, Barnadas A, Leonard RC, Marangolo M, Untch M, Ukarma L, Burger H-U, Scherhag A, Osterwalder B (2009) What is the impact of antithrombotic therapy and risk factors on the frequency of thrombo-vascular events in patients with metastatic breast cancer receiving epoetin beta? Eur J Cancer, epub ahead of print, 29 July 2009, doi:10.1016/j.ejca.2009.06.31
4. Aapro M, Link H (2008) September 2007 Update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. The Oncologist 13 (suppl 3): 33–36
5. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, Verma A (2001) Erythropoietin and erythropietin receptor expression in human cancer. Cancer Res 61: 3561–3565
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献